{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T13:38:21Z","timestamp":1775137101501,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["15-15-00121"],"award-info":[{"award-number":["15-15-00121"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["16-03-00374"],"award-info":[{"award-number":["16-03-00374"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.bmc.2018.07.039","type":"journal-article","created":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T23:33:36Z","timestamp":1532388816000},"page":"4470-4480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Synthesis and evaluation of aryliden- and hetarylidenfuranone derivatives of usnic acid as highly potent Tdp1 inhibitors"],"prefix":"10.1016","volume":"26","author":[{"given":"Olga","family":"Zakharova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Luzina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Zakharenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry","family":"Sokolov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandr","family":"Filimonov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadezhda","family":"Dyrkheeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arina","family":"Chepanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Ilina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ilyina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Klabenkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Chelobanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry","family":"Stetsenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chatchakorn","family":"Eurtivong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f3hannes","family":"Reynisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4083-9324","authenticated-orcid":false,"given":"Konstantin","family":"Volcho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nariman","family":"Salakhutdinov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Lavrik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2018.07.039_b0005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.chembiol.2010.04.012","article-title":"DNA topoisomerases and their poisoning by anticancer and antibacterial drugs","volume":"17","author":"Pommier","year":"2010","journal-title":"Chem Biol"},{"key":"10.1016\/j.bmc.2018.07.039_b0010","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3109\/03602532.2014.971957","article-title":"Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target","volume":"46","author":"Comeaux","year":"2014","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.bmc.2018.07.039_b0015","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1016\/j.bmc.2016.09.045","article-title":"Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential","volume":"24","author":"Laev","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2018.07.039_b0020","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2174\/187152008784220357","article-title":"Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy","volume":"8","author":"Dexheimer","year":"2008","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.bmc.2018.07.039_b0025","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature08444","article-title":"A novel human 5\u2019-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage","volume":"461","author":"Cortes Ledesma","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2018.07.039_b0030","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1093\/nar\/gkm463","article-title":"Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1","volume":"35","author":"Antony","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2018.07.039_b0035","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1021\/jm3014458","article-title":"Synthesis and biological evaluation of Indenoisoquinolines that Inhibit Both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1)","volume":"56","author":"Conda-Sheridan","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.07.039_b0040","doi-asserted-by":"crossref","first-page":"8671","DOI":"10.1021\/jm3008773","article-title":"5-Arylidenethioxothiazolidinones as Inhibitors of Tyrosyl\u2013DNA Phosphodiesterase I","volume":"55","author":"Sirivolu","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.07.039_b0045","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1021\/acs.jmedchem.6b01565","article-title":"Synthesis and biological evaluation of the first triple inhibitors of human topoisomerase 1, tyrosyl\u2212DNA phosphodiesterase 1 (Tdp1), and tyrosyl\u2212DNA phosphodiesterase 2 (Tdp2)","volume":"60","author":"Wang","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.07.039_b0050","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.bmc.2015.03.020","article-title":"Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety","volume":"23","author":"Zakharenko","year":"2015","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"10.1016\/j.bmc.2018.07.039_b0055","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1021\/acs.jmedchem.5b00136","article-title":"Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1) \u2212 tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors","volume":"58","author":"Nguyen","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.07.039_b0060","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1039\/C5MD00245A","article-title":"A synthesis, in silico, in vitro and in vivo study of thieno[2,3-b]pyridine anticancer analogues","volume":"6","author":"Arabshahi","year":"2015","journal-title":"Med Chem Commun"},{"issue":"1","key":"10.1016\/j.bmc.2018.07.039_b0065","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bmc.2009.11.008","article-title":"Inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1) developed by virtual screening using ligand-based pharmacophores","volume":"18","author":"Weidlich","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2018.07.039_b0070","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural products as sources of new drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2018.07.039_b0075","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1515\/pac-2017-0109","article-title":"Monoterpenes as a renewable source of biologically active compounds","volume":"89","author":"Salakhutdinov","year":"2017","journal-title":"Pure Appl Chem"},{"issue":"22","key":"10.1016\/j.bmc.2018.07.039_b0080","doi-asserted-by":"crossref","first-page":"7122","DOI":"10.1021\/jm901061s","article-title":"4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors","volume":"52","author":"Dexheimer","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.07.039_b0085","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.bmcl.2017.07.062","article-title":"Achyrodimer F, a tyrosyl-DNA phosphodiesterase I inhibitor from an Australian fungus of the family Cortinariaceae","volume":"27","author":"Tian","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2018.07.039_b0090","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1016\/j.bmc.2016.09.016","article-title":"New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties","volume":"24","author":"Khomenko","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2018.07.039_b0095","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1134\/S1068162015060199","volume":"41","author":"Zakharenko","year":"2015","journal-title":"Rus J Bioorg Chem"},{"key":"10.1016\/j.bmc.2018.07.039_b0100","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1021\/acs.jnatprod.6b00979","article-title":"Tyrosyl-DNA phosphodiesterase 1 inhibitors: usnic acid enamines enhance the cytotoxic effect of camptothecin","volume":"79","author":"Zakharenko","year":"2016","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2018.07.039_b0105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1134\/S1068162016020084","article-title":"Biological activity of usnic acid and its derivatives: part 1. activity against unicellular organisms","volume":"42","author":"Luzina","year":"2016","journal-title":"Russ J Bioorg Chem"},{"key":"10.1016\/j.bmc.2018.07.039_b0110","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1134\/S1068162016030109","article-title":"Biological activity of usnic acid and its derivatives: part 2. effects on higher organisms. molecular and physicochemical aspects","volume":"42","author":"Luzina","year":"2016","journal-title":"Russ J Bioorg Chem"},{"key":"10.1016\/j.bmc.2018.07.039_b0115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/cmdc.201200503","article-title":"Synthesis of a potent antimalarial agent through natural products conjugation","volume":"8","author":"Bruno","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2018.07.039_b0120","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1016\/j.bmc.2014.10.033","article-title":"Novel derivatives of usnic acid effectively inhibiting reproduction of influenza A virus","volume":"22","author":"Shtro","year":"2014","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"10.1016\/j.bmc.2018.07.039_b0125","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1007\/s00044-015-1348-2","article-title":"Synthesis and activity of (+)-usnic acid and (\u2212)-usnic acid derivatives containing 1,3-thiazole cycle against Mycobacterium tuberculosis","volume":"24","author":"Bekker","year":"2015","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmc.2018.07.039_b0130","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/19960402NT7","article-title":"Lichen acids as uncouplers of oxidative phosphorylation of mouse-liver mitochondria","volume":"4","author":"Abo-Khatwa","year":"1996","journal-title":"Nat Toxins"},{"key":"10.1016\/j.bmc.2018.07.039_b0135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10600-012-0258-5","article-title":"Synthesis of aurones based on usninic acid","volume":"48","author":"Luzina","year":"2012","journal-title":"Chem Nat Compd"},{"key":"10.1016\/j.bmc.2018.07.039_b0140","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nsb1203-980","article-title":"Announcing the worldwide protein data bank","volume":"10","author":"Berman","year":"2003","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.bmc.2018.07.039_b0145","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/bjc.1996.362","article-title":"Current perspectives on camptothecins in cancer treatment","volume":"74","author":"Dancey","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bmc.2018.07.039_b0150","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.critrevonc.2009.08.001","article-title":"Review role of topotecan in gynaecological cancers: current indications and perspectives","volume":"74","author":"Lorusso","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.bmc.2018.07.039_b0155","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1634\/theoncologist.12-10-1194","article-title":"Recent advances with topotecan in the treatment of lung cancer","volume":"12","author":"O'Brien","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.bmc.2018.07.039_b0160","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0022-2836(02)01154-3","article-title":"Crystal structure of a human tyrosyl-DNA phosphodiesterase (Tdp1)-tungstate complex","volume":"324","author":"Davies","year":"2003","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmc.2018.07.039_b0165","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmc.2018.07.039_b0170","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1023\/A:1007996124545","article-title":"Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes","volume":"11","author":"Eldridge","year":"1997","journal-title":"J Comp Aid Mol Design"},{"key":"10.1016\/j.bmc.2018.07.039_b0175","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1021\/jm050543p","article-title":"Modelling water in protein-ligand docking using GOLD","volume":"48","author":"Verdonk","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2018.07.039_b0180","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/ci800298z","article-title":"Empirical scoring functions for advanced protein\u2212ligand docking with PLANTS","volume":"49","author":"Korb","year":"2009","journal-title":"J Chem Inf Model"},{"issue":"2","key":"10.1016\/j.bmc.2018.07.039_b0185","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/prot.20588","article-title":"General and targeted statistical potentials for protein\u2013ligand interactions","volume":"61","author":"Mooij","year":"2005","journal-title":"Proteins"},{"key":"10.1016\/j.bmc.2018.07.039_b0190","series-title":"DNA Topoisomerases and Cancer","first-page":"335","article-title":"Tyrosyl-DNA-Phosphodiesterase","author":"Dexheimer","year":"2012"},{"key":"10.1016\/j.bmc.2018.07.039_b0195","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/minf.201200103","article-title":"Wine compounds as a source for HTS screening collections. A feasibility study","volume":"31","author":"Zhu","year":"2012","journal-title":"Mol Inf"},{"key":"10.1016\/j.bmc.2018.07.039_b0200","article-title":"RU Pat. No. 2,317,076 C1","volume":"5","author":"Salakhutdinov","year":"2008","journal-title":"Byull Izobret"},{"key":"10.1016\/j.bmc.2018.07.039_h0205","doi-asserted-by":"crossref","first-page":"12009","DOI":"10.1073\/pnas.211429198","article-title":"The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily","volume":"98","author":"Interthal","year":"2001","journal-title":"J Proc Natl Acad Sci. USA"},{"key":"10.1016\/j.bmc.2018.07.039_h0210","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.febslet.2011.01.032","article-title":"AP-site cleavage activity of tyrosyl-DNA phosphodiesterase 1","volume":"585","author":"Lebedeva","year":"2011","journal-title":"FEBS Lett"},{"issue":"2","key":"10.1016\/j.bmc.2018.07.039_b0210","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1134\/S106816201602014X","article-title":"Removal of acid-labile protecting or anchoring groups in the presence of polyfluorinated alcohol: application to solid-phase peptide synthesis","volume":"42","author":"Stetsenko","year":"2016","journal-title":"Russ. J. Bioorg. Chem."},{"issue":"24","key":"10.1016\/j.bmc.2018.07.039_b0215","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.1021\/ol303124r","article-title":"New TFA-free cleavage and final deprotection in Fmoc solid-phase peptide synthesis: dilute HCl in fluoro alcohol","volume":"14","author":"Palladino","year":"2012","journal-title":"Org Lett"},{"key":"10.1016\/j.bmc.2018.07.039_b0220","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"Immunol Methods"},{"issue":"2","key":"10.1016\/j.bmc.2018.07.039_b0225","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0969-2126(02)00707-4","article-title":"The Crystal Structure of Human Tyrosyl-DNA Phosphodiesterase, Tdp1","volume":"10","author":"Davies","year":"2002","journal-title":"Structure"},{"key":"10.1016\/j.bmc.2018.07.039_b0230","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucl Acids Res"},{"key":"10.1016\/j.bmc.2018.07.039_b0235","unstructured":"Scigress v2.6, Fijitsu Limited: 2008\u20132016."},{"key":"10.1016\/j.bmc.2018.07.039_b0240","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1021\/ja00467a001","article-title":"Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms","volume":"99","author":"Allinger","year":"1977","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2018.07.039_b0245","unstructured":"QikProp v3.2, Schr\u00f6dinger, New York, 2009."},{"key":"10.1016\/j.bmc.2018.07.039_b0250","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/qsar.200730051","article-title":"Benchmarking the reliability of QikProp. Correlation between experimental and predicted values","volume":"27","author":"Ioakimidis","year":"2008","journal-title":"QSAR Comb Sci"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089618306576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089618306576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:57:08Z","timestamp":1760835428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089618306576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":51,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0968089618306576"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2018.07.039","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of aryliden- and hetarylidenfuranone derivatives of usnic acid as highly potent Tdp1 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2018.07.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}